Cyclotec Advanced Medical Technologies, Inc. to Present at Medtech Insight's ``Investment In Innovation'' Conference.Business Editors Medtech Insight 2004 Investment in Innovation IRVINE, Calif.--(BUSINESS WIRE)--Feb. 18, 2004 Cyclotec Advanced Medical Technologies, Inc. will be presenting on February 24 at 4:45 p.m. at Medtech Insight's Prestigious "Investment In Innovation" Event, taking place February 24-25, 2004 at the Hyatt Regency Irvine in Irvine, California. Cyclotec Advanced Medical Technology, Inc. is revolutionizing pain control. The company's innovative electronic devices have earned it the prestigious R&D100 Award in 2002 for "one of the 100 most technologically significant new products of the year -- worldwide." The R&D100 Award is the most prestigious honor in applied research, with past recipients including Polacolor film, the fax machine, the liquid crystal display liquid crystal display (LCD) Optoelectronic device used in displays for watches, calculators, notebook computers, and other electronic devices. Current passed through specific portions of the liquid crystal solution causes the crystals to align, blocking the passage of light. , the laser printer, the Nicoderm patch, and Taxol anticancer drug anticancer drug see antineoplastic. anticancer drug Chemotherapeutic, see there . According to the New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of Times, "Disabling pain affects millions of Americans and costs more than $90 billion dollars a year in health care and lost work." Chronic pain is the number one cause of adult disability in the United States, affecting approximately 50 million Americans and resulting in direct health care expenditures of more than $20 billion annually. In addition, acute pain incidents including sports injuries Sports Injuries Definition Sports injuries result from acute trauma or repetitive stress associated with athletic activities. Sports injuries can affect bones or soft tissue (ligaments, muscles, tendons). , fractures, cuts, burns and bruises number in the hundreds of millions each year. With this market in mind, ten years and more than $5 million have been invested in developing Cyclotec AMT's unprecedented new products, based on TENS (Transcutaneous Electrical Nerve Stimulation transcutaneous electrical nerve stimulation n. TENS. Transcutaneous electrical nerve stimulation (TENS) A method for relieving the muscle pain of TMJ by stimulating nerve endings that do not transmit pain. ) technology. TENS applies a small electric current to nerve pain receptors to block pain and inducing release of endorphins endorphins (ĕndôr`fĭnz), neurotransmitters found in the brain that have pain-relieving properties similar to morphine. There are three major types of endorphins: beta endorpins, found primarily in the pituitary gland; and enkephalins and . For 30 years, TENS has proven safe and effective. It has FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval, and is approved for reimbursement by Medicare and all medical insurance companies. Competitors' TENS devices are confusing and inconvenient to use, requiring wires to connect control units to the electrodes. Cyclotec AMT See vPro. has re-thought TENS, making it small, convenient, affordable -- and wireless. The company's devices work quickly, safely and effectively as an alternative to drugs for both chronic and acute pain applications, eliminating drug-related side effects or risk of addiction. As many as four CT2 receiver/stimulator modules are fully operable operable /op·er·a·ble/ (op´er-ah-b'l) subject to being operated upon with a reasonable degree of safety; appropriate for surgical removal. op·er·a·ble adj. via the CT2 radio frequency remote controller, allowing for multiple site applications and simplifying use in areas not easily reached by the patient and under clothing. CT1 offers a non-remote, lower-cost alternative to CT2. Nearing production, CT4 is a very low cost, ultra-miniaturized device intended to become the world's first over-the-counter, electronic pain-relief sterile bandage. Also in development, CT3 will be integrated into splints splints inflammation of the interosseous ligament between the small and large metacarpal bones of horses and an accompanying periostitis and exostosis production on the small metacarpal bone. The metatarsal bones are similarly but less frequently involved. , braces and casts, and CT5 and CT6 neuromuscular stimulators will provide for physical therapy needs. Distribution networks are being established worldwide. Cyclotec AMT's innovation has been supported in part by significant grant awards from the National Institute on Drug Abuse The National Institute on Drug Abuse (NIDA) is a United States federal-government research institute whose mission is to "lead the Nation in bringing the power of science to bear on drug abuse and addiction. , a division of the National Institute of Health, and the U.S. Department of Energy. Toll-free: 1-866-446-8724 www.CyclotecAMT.com. About Medtech Insight Medtech Insight's "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conferences are considered the premier forum for senior executives in the medical technology and investment community to preview emerging medtech companies in need of funding, acquisition and/or strategic partnership. In addition to conferences, Medtech Insight publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry, analyses of medtech markets through its Reports group, and offers custom consulting and market research. To register for the Irvine conference or for more information on Medtech Insight, please call Scott Pantel at 949-219-0150 or 888-290-2225 toll-free in the U.S., e-mail in3@medtechinsight.com, or visit http://www.medtechinsight.com/in3-10.html. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion